State Street Corporation 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 2:04 pm Sale |
2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
222,594 1.710% |
-729,432 (-76.62%) |
Filing |
| 2023-02-03 4:08 pm Purchase |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
952,026 7.310% |
243,802 (+34.42%) |
Filing |
| 2022-02-11 09:41 am Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
708,224 5.480% |
-105,877 (-13.01%) |
Filing |
| 2021-02-08 1:14 pm Purchase |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
814,101 6.250% |
203,510 (+33.33%) |
Filing |